Upfront Allogeneic Transplantation Versus JAK Inhibitor Therapy for Patients with Myelofibrosis: A North American Collaborative Study

Citation:

Maze, D. , Shi, Y. , Gupta, V. , & et al., . (2023). Upfront Allogeneic Transplantation Versus JAK Inhibitor Therapy for Patients with Myelofibrosis: A North American Collaborative Study.

Download Citation

• BibTex
• Tagged
• XML

Abstract:

Notes:

Last updated on 10/31/2023